marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-04-2024
Anika Therapeutics Financial Ratios 2011-2024 | ANIK
Annual Financial Ratios Anika Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.5 | -27.3 | 110.8 | -21.9 | 22.3 | 29.3 | 31.2 | 22.4 | 18.3 | 15.0 | 22.9 | 12.0 | 14.0 |
P/S |
2.2 | 2.6 | 3.1 | 4.0 | 5.3 | 5.2 | 8.8 | 7.1 | 6.0 | 5.4 | 6.3 | 2.0 | 1.8 |
EPS |
-5.6 | -1.0 | 0.3 | -1.7 | 1.9 | 1.3 | 2.2 | 2.2 | 2.1 | 2.6 | 1.5 | 0.9 | 0.7 |
EV (Enterprise Value) |
300 M | 319 M | 364 M | 431 M | 491 M | 474 M | 880 M | 643 M | 476 M | 491 M | 429 M | 130 M | 121 M |
EBITDA per Share |
-5.54 | -0.87 | 0.63 | -1.56 | 2.85 | 1.92 | 3.43 | 3.7 | 3.48 | 4.51 | 2.63 | 2.02 | 1.38 |
EV/EBITDA |
38.7 | -429.8 | 11.2 | 16.6 | 17.2 | 11.5 | 8.7 | 7.2 | 11.0 | 4.0 | 5.2 | ||
PEG |
-0.43 | 0.26 | -1.86 | 0.73 | 0.46 | -0.72 | -17.34 | 2.89 | -0.87 | 0.19 | 0.36 | 0.33 | 0.15 |
P/B |
1.4 | 1.2 | 1.3 | 1.4 | 2.1 | 2.1 | 3.8 | 3.3 | 2.7 | 3.2 | 3.5 | 1.3 | 1.3 |
P/CF |
-208.5 | 92.0 | 54.5 | 40.3 | 17.7 | 18.1 | 31.2 | 74.6 | 18.8 | 15.0 | 19.1 | 15.6 | 13.6 |
ROE % |
-38.95 | -5.20 | 1.44 | -8.80 | 9.43 | 7.10 | 12.07 | 14.61 | 14.59 | 21.52 | 15.17 | 10.79 | 8.93 |
ROA % |
-30.55 | -4.26 | 1.19 | -6.56 | 8.22 | 6.71 | 11.26 | 13.55 | 13.05 | 19.75 | 13.19 | 8.28 | 6.37 |
ROCE % |
-41.29 | -6.79 | 0.91 | -10.40 | 10.89 | 8.12 | 16.97 | 21.87 | 22.03 | 32.68 | 22.02 | 17.44 | 11.81 |
Current Ratio |
- | - | - | - | 14.4 | 18.3 | 15.8 | 19.4 | 10.2 | 23.3 | 10.2 | 5.4 | 4.4 |
DSO |
77.3 | 75.3 | 66.6 | 66.0 | 73.5 | 71.8 | 76.7 | 97.4 | 85.0 | 59.3 | 91.1 | 109.8 | 97.5 |
DIO |
247.3 | 220.7 | 231.4 | 202.6 | 279.3 | 293.3 | 293.9 | 242.8 | 259.0 | 216.4 | 176.3 | 104.3 | 99.5 |
DPO |
54.4 | 48.7 | 46.8 | 38.1 | 48.7 | 36.7 | 90.0 | 35.0 | 143.9 | 20.9 | 44.8 | 29.5 | 58.6 |
Operating Cycle |
324.6 | 296.0 | 298.0 | 268.6 | 352.8 | 365.1 | 370.6 | 340.2 | 344.0 | 275.6 | 267.4 | 214.1 | 197.0 |
Cash Conversion Cycle |
270.2 | 247.3 | 251.2 | 230.6 | 304.1 | 328.4 | 280.6 | 305.3 | 200.0 | 254.7 | 222.6 | 184.6 | 138.4 |
All numbers in USD currency
Quarterly Financial Ratios Anika Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.03 | -0.01 | -0.31 | - | -0.45 | -0.19 | -0.71 | - | -0.29 | -0.2 | -0.2 | - | 0.04 | 0.45 | 0.2 | -1.1 | -0.45 | -0.54 | 0.41 | 0.28 | 0.65 | 0.68 | 0.32 | 0.54 | 0.53 | 0.69 | -0.46 | 0.55 | 0.47 | 0.78 | 0.38 | 0.56 | 0.61 | 0.59 | 0.46 | 0.74 | 0.56 | 0.52 | 0.24 | 0.53 | 0.42 | 0.63 | 1.04 | 0.47 | 0.36 | 0.44 | 0.23 | 0.33 | 0.12 | 0.28 | 0.15 | 0.22 | 0.23 | 0.18 | 0.03 |
EBITDA per Share |
-1.88 | 0.04 | -0.23 | - | -0.39 | -0.11 | -0.75 | - | -0.06 | -0.1 | -0.13 | - | 0.42 | 0.78 | 0.2 | - | -0.24 | -0.22 | 0.69 | - | 1.17 | 1.07 | 0.49 | - | 0.91 | 0.97 | -0.43 | - | 0.93 | 1.35 | 0.62 | - | 1.13 | 1.05 | 0.78 | - | 1.06 | 0.95 | 0.43 | - | 0.94 | 1.2 | 1.73 | - | 0.83 | 0.86 | 0.46 | - | 0.46 | 0.63 | 0.31 | - | 0.61 | 0.44 | 0.12 |
ROE % |
-21.27 | -7.07 | -8.03 | -7.16 | -8.63 | -7.66 | -7.65 | -3.49 | -3.29 | -1.64 | 1.64 | 3.50 | -2.25 | -4.80 | -9.91 | -8.80 | -1.65 | 3.89 | 9.99 | 9.43 | 10.95 | 10.64 | 11.20 | 7.10 | 7.24 | 6.97 | 7.45 | 12.07 | 12.64 | 14.05 | 13.60 | 14.61 | 16.22 | 16.17 | 16.02 | 14.59 | 13.74 | 13.23 | 14.74 | 21.52 | 22.03 | 22.22 | 21.35 | 15.17 | 14.36 | 12.22 | 11.30 | 10.79 | 9.74 | 11.37 | 10.35 | 8.93 | 3.14 | 2.41 | 0.34 |
ROA % |
-14.67 | -2.58 | -3.38 | -4.72 | -5.09 | -6.29 | -6.31 | -2.91 | -2.76 | -0.54 | 1.26 | 2.74 | -1.54 | -3.45 | -7.36 | -6.56 | -1.05 | 3.48 | 8.44 | 8.22 | 9.76 | 9.71 | 10.47 | 6.71 | 6.80 | 6.51 | 6.92 | 11.26 | 11.77 | 13.06 | 12.62 | 13.55 | 14.87 | 14.69 | 14.43 | 13.05 | 12.42 | 12.04 | 13.52 | 19.78 | 19.99 | 19.98 | 18.97 | 13.19 | 12.06 | 10.04 | 8.90 | 8.28 | 7.30 | 8.39 | 7.48 | 6.37 | 2.24 | 1.72 | 0.24 |
ROCE % |
-20.77 | -8.03 | -9.43 | -8.68 | -10.72 | -9.92 | -9.77 | -4.46 | -4.01 | -1.53 | 2.85 | 4.10 | 1.19 | -2.16 | -8.87 | -3.81 | 0.37 | 7.46 | 15.09 | 10.21 | 13.46 | 12.54 | 12.67 | 4.55 | 8.44 | 9.09 | 11.55 | 13.66 | 19.81 | 22.06 | 21.37 | 17.00 | 23.23 | 23.31 | 23.16 | 14.73 | 20.51 | 20.06 | 22.70 | 27.71 | 33.44 | 33.39 | 31.78 | 16.35 | 18.85 | 15.63 | 14.33 | 10.95 | 16.03 | 18.61 | 16.86 | 9.55 | 5.08 | 3.88 | 0.59 |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
73.2 | 71.7 | 76.6 | - | - | 69.4 | 36.9 | - | - | - | 37.1 | - | 71.3 | 66.9 | 67.3 | 67.3 | 69.4 | 71.7 | 60.8 | 70.7 | 70.9 | 69.2 | 80.9 | 70.3 | 70.8 | 62.1 | 95.7 | 74.0 | 80.0 | 65.0 | 100.3 | 87.7 | 97.7 | 94.7 | 100.8 | 64.0 | 83.4 | 86.3 | 114.1 | 67.3 | 71.0 | 59.6 | 48.1 | 80.5 | 96.3 | 82.1 | 120.3 | 86.6 | 132.6 | 99.8 | 123.2 | 85.6 | 85.6 | 97.8 | - |
DIO |
111.4 | 316.2 | 275.0 | - | - | 249.8 | 245.3 | - | 97.2 | 108.6 | 218.3 | - | 215.2 | 225.3 | 304.6 | - | 293.8 | 249.0 | 219.1 | 232.1 | 337.3 | 293.6 | 270.2 | 277.6 | 234.7 | 238.4 | 252.0 | 230.7 | 321.7 | 318.4 | 285.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
20.5 | 62.7 | 57.1 | - | - | 50.3 | 54.5 | - | 21.8 | 23.0 | 46.2 | - | 44.3 | 44.2 | 60.5 | - | 57.1 | 48.4 | 41.2 | 40.4 | 58.8 | 51.1 | 43.5 | 41.0 | 34.6 | 35.2 | 57.5 | 70.6 | 98.5 | 97.5 | 67.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
184.5 | 387.9 | 275.0 | - | - | 319.1 | 282.2 | - | 97.2 | 108.6 | 255.4 | - | 286.5 | 292.2 | 372.0 | 67.3 | 363.2 | 320.7 | 279.9 | 302.8 | 408.2 | 362.8 | 351.1 | 347.9 | 305.4 | 300.5 | 347.7 | 304.7 | 401.7 | 383.4 | 385.5 | 87.7 | 97.7 | 94.7 | 100.8 | 64.0 | 83.4 | 86.3 | 114.1 | 67.3 | 71.0 | 59.6 | 48.1 | 80.5 | 96.3 | 82.1 | 120.3 | 86.6 | 132.6 | 99.8 | 123.2 | 85.6 | 85.6 | 97.8 | - |
Cash Conversion Cycle |
164.0 | 325.1 | 217.9 | - | - | 268.9 | 227.6 | - | 75.4 | 85.7 | 209.2 | - | 242.1 | 248.0 | 311.5 | 67.3 | 306.1 | 272.2 | 238.8 | 262.4 | 349.4 | 311.7 | 307.6 | 307.0 | 270.8 | 265.3 | 290.2 | 234.0 | 303.2 | 285.9 | 317.6 | 87.7 | 97.7 | 94.7 | 100.8 | 64.0 | 83.4 | 86.3 | 114.1 | 67.3 | 71.0 | 59.6 | 48.1 | 80.5 | 96.3 | 82.1 | 120.3 | 86.6 | 132.6 | 99.8 | 123.2 | 85.6 | 85.6 | 97.8 | - |
All numbers in USD currency